← Leaderboard
HIMS
Ticker
HIMS
Congressional Trades
3
by 2 members
Buys
3
100%
Sells
0
0%
Total Volume
$766K
midpoint
Unique Traders
2
members
Party Breakdown
Democrats0 · 0%
Republicans3 · 100%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
—
Aug '25
2▲
—
Feb '26
1▲
Democrats0▲0▼Neutral
vs
Republicans3▲0▼Net buyers
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-04-20$360KHIMS & HERS HEALTH INC.Matters related to compounding, telehealth, and healthcare
- 2026-04-17$60KHIMS & HERS HEALTH INC.Compounding / telehealth / healthcare
- 2026-04-09$60KHIMS & HERS HEALTH INC.Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
- 2026-01-23$330KHIMS & HERS HEALTH INC.Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
- 2026-01-23$320KHIMS & HERS HEALTH INC.Telehealth Compounded medicines Quality and safety manufacturing
- 2026-01-23$240KHIMS & HERS HEALTH INC.Drug shortage list FDA transparency
- 2026-01-20$60KHIMS & HERS HEALTH INC. (FORMERLY HIMS INC)Compounding / telehealth / healthcare Compounding / telehealth / healthcare
- 2026-01-16$280KHIMS & HERS HEALTH INC.Matters related to compounding, telehealth, and healthcare
- 2026-01-15$60KHIMS & HERS HEALTH INC.Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
- 2025-10-20$320KHIMS & HERS HEALTH INC.Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
▲100
3 buys3 total0 sells
$766K buys · $0 sells
Cumulative Net Position (buy vol − sell vol)
+$766K
2025-083 trades plotted2026-02
Trade Activity Timeline
Congressional buys & sells by month · last 2 months w/ activity
25/08
26/02
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade2 buyers ·0 sellers
BuySellOtherDot size ∝ trade size · top 2 most-active traders shown
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay |
|---|---|---|---|---|
| 2026-02-03 | RTony Wied | BUY | $500K – $1.0M | 34d |
| 2025-08-04 | RLisa McClain | BUY | $1K – $15K | 42d |
| 2025-08-04 | RLisa McClain | BUY | $1K – $15K | 39d |